Skip to main content
OpenTrials

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,659 public trials 307 recruiting studies
Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Recruiting

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

NCT07266831

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Ruane Clinical Research Group, Inc. ( Site 1513) Los Angeles, California, United States
  • Vivent Health ( Site 1519) Denver, Colorado, United States
  • Whitman-Walker Institute ( Site 1538) Washington D.C., District of Columbia, United States
  • Midway Immunology and Research Center ( Site 1503) Ft. Pierce, Florida, United States
View all 55 locations
View Trial Details
Recruiting

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

NCT07476339

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • CAN Community Health Clearwater, Florida, United States
  • Midway Specialty Care Center Ft. Pierce, Florida, United States
  • CAN Community Health Jacksonville, Florida, United States
  • CAN Community Health Orlando, Florida, United States
View Trial Details
Recruiting

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

NCT05077527

Conditions
AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, Blood-Borne Infections, +36 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Montefiore Medical Center - Moses Campus The Bronx, New York, United States
View Trial Details
Recruiting

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

NCT04375800

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • University of Colorado at Denver ( Site 0108) Aurora, Colorado, United States
  • Emory Children's Center ( Site 0103) Atlanta, Georgia, United States
  • Clinica Somer ( Site 1003) Rionegro, Antioquia, Colombia
  • Ciensalud Ips S A S ( Site 1001) Barranquilla, Atlántico, Colombia
View all 24 locations
View Trial Details

Related conditions